Alzheimer's disease patients who are taking a commonly prescribed drug can still benefit from it after they progress to moderate-to-severe illness, when it can be tough to tell whether it's doing any good, …
The rest is here:
Aricept helps moderate ... continue reading
A method of classifying brain atrophy patterns in Alzheimer’s disease patients using MRIs can also detect cognitive decline in Parkinson’s disease, according to a new study. Researchers also found that higher baseline Alzheimer’s patterns of atrophy predicted long-term cognitive decline in cognitively normal Parkinson’s patients. The study is published online ... continue reading
(Reuters) – An experimental drug being developed by Roche Holding AG removed amyloid plaques from the brains of Alzheimer’s disease patients in a small early-stage study, according to data published in the Archives of Neurology, the Swiss drugmaker said on Monday.
Read the original here:
... continue reading
Research and Markets has announced the addition of the “Alzheimer’s Disease Patients & Market Worldwide, Future Scenario & Drugs Analysis” report to their offering.
More here:
Research and Markets: Alzheimer’s Disease Patients ... continue reading